Zhang Xiao-Jia, Yan Mei, Liu Yu, Wang Xue-Mei, Nuriding Hailiqiguli
Department of Pediatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2014 Feb;16(2):147-51.
To investigate the effects of Huangqi injection on the infection factors in children with acute lymphoblastic leukemia (ALL) during remission induction chemotherapy.
Ninety-one children with ALL were divided into treatment (n=47) and control groups (n=44) by a randomized double-blind method. During remission induction chemotherapy, the treatment group was given Huangqi injection (0.5 mL/kg·d) for 35 days, while an equal volume of normal saline was used instead in the control group; the other supportive care was the same for the two groups. After remission induction chemotherapy, the incidence of infection, duration of infection, white blood cell and neutrophil counts, site of infection, and positive rate of pathogenic bacteria in secretion were compared between the two groups.
Four cases in the treatment group dropped out of the study due to allergic reaction. After remission induction chemotherapy, compared with the control group, the treatment group had a significantly lower incidence of infection (P<0.05), a shorter duration of infection at any site (P<0.05), a higher neutrophil count after chemotherapy (P<0.05), and lower incidence rates of respiratory tract infection, urinary tract infection, blood infection, and skin and soft tissue infections (P<0.05). Gram-negative bacteria were the main pathogens. Among the infected children, the positive rate of pathogenic bacteria in secretion was significantly lower in the treatment group than in the control group (P<0.05).
Huangqi injection may reduce bone marrow suppression caused by chemotherapy drugs and increase neutrophil count during remission induction chemotherapy to reduce the incidence and duration of infection in children with ALL.
探讨黄芪注射液对急性淋巴细胞白血病(ALL)患儿缓解诱导化疗期间感染因素的影响。
采用随机双盲法将91例ALL患儿分为治疗组(n = 47)和对照组(n = 44)。在缓解诱导化疗期间,治疗组给予黄芪注射液(0.5 mL/kg·d),共35天,而对照组则使用等量的生理盐水替代;两组的其他支持治疗相同。缓解诱导化疗后,比较两组的感染发生率、感染持续时间、白细胞和中性粒细胞计数、感染部位以及分泌物中病原菌的阳性率。
治疗组有4例因过敏反应退出研究。缓解诱导化疗后,与对照组相比,治疗组的感染发生率显著降低(P<0.05),任何部位的感染持续时间均较短(P<0.05),化疗后的中性粒细胞计数较高(P<0.05),呼吸道感染、泌尿系统感染、血液感染以及皮肤和软组织感染的发生率较低(P<0.05)。革兰阴性菌是主要病原体。在感染患儿中,治疗组分泌物中病原菌的阳性率显著低于对照组(P<0.05)。
黄芪注射液可能减轻化疗药物引起的骨髓抑制,并在缓解诱导化疗期间增加中性粒细胞计数,以降低ALL患儿的感染发生率和持续时间。